{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T18:51:05Z","timestamp":1789757465155,"version":"4.0.1"},"reference-count":38,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Suzhou Clinical Research Center of Neurological Disease","award":["Szzx201503"],"award-info":[{"award-number":["Szzx201503"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81471299"],"award-info":[{"award-number":["81471299"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Jiangsu Provincial Special Program of Medical Science","award":["BL2014042"],"award-info":[{"award-number":["BL2014042"]}]},{"name":"Suzhou Clinical Key Disease Diagnosis and Treatment Technology Foundation","award":["LCZX201304"],"award-info":[{"award-number":["LCZX201304"]}]},{"name":"Plans for Graduate Research and Innovation in Colleges and Universities of Jiangsu Province","award":["KYZZ15_0334"],"award-info":[{"award-number":["KYZZ15_0334"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["NeuroToxicology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/j.neuro.2016.11.006","type":"journal-article","created":{"date-parts":[[2016,11,17]],"date-time":"2016-11-17T21:32:49Z","timestamp":1479418369000},"page":"103-109","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":117,"special_numbering":"C","title":["Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish"],"prefix":"10.1016","volume":"58","author":[{"given":"Yali","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenwen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yizhen","family":"Sima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhao-min","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Fang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Feng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuro.2016.11.006_bib0005","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/81834","article-title":"Chronic systemic pesticide exposure reproduces features of Parkinson's disease","volume":"3","author":"Betarbet","year":"2000","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuro.2016.11.006_bib0010","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1016\/j.ntt.2004.06.014","article-title":"Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease","volume":"26","author":"Bretaud","year":"2004","journal-title":"Neurotoxicol. Teratol."},{"key":"10.1016\/j.neuro.2016.11.006_bib0015","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.nbd.2012.06.025","article-title":"Gene-environment interactions in Parkinson's disease: specific evidence in humans and mammalian models","volume":"57","author":"Cannon","year":"2013","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2016.11.006_bib0020","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbr.2010.06.001","article-title":"Translating rodent behavioral repertoire to zebrafish (Danio rerio): relevance for stress research","volume":"214","author":"Champagne","year":"2010","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.neuro.2016.11.006_bib0025","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.psyneuen.2016.03.008","article-title":"The role of medial prefrontal corticosterone and dopamine in the antidepressant-like effect of exercise","volume":"69","author":"Chen","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/j.neuro.2016.11.006_bib0030","doi-asserted-by":"crossref","first-page":"10993","DOI":"10.1523\/JNEUROSCI.2993-04.2004","article-title":"Chronic exposure to rotenone models sporadic Parkinson's disease in Drosophila melanogaster","volume":"24","author":"Coulom","year":"2004","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2016.11.006_bib0035","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1212\/WNL.38.8.1237","article-title":"Olfactory dysfunction in parkinsonism: a general deficit unrelated to neurologic signs, disease stage, or disease duration","volume":"38","author":"Doty","year":"1988","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2016.11.006_bib0040","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1212\/WNL.43.5.962","article-title":"Olfactory testing differentiates between progressive supranuclear palsy and idiopathic Parkinson's disease","volume":"43","author":"Doty","year":"1993","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2016.11.006_bib0045","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/j.nbd.2011.10.026","article-title":"Olfaction in Parkinson's disease and related disorders","volume":"46","author":"Doty","year":"2012","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuro.2016.11.006_bib0050","unstructured":"Fahn S, E. R. M. o. t. U. D. C., 1987. Unified Parkinson\u2019s disease rating scale.In: Fahn S et al., editors. Recent developments in Parkinson\u2019s disease. Florham, NJ: Macmillian Healthcare."},{"key":"10.1016\/j.neuro.2016.11.006_bib0055","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.parkreldis.2008.04.038","article-title":"The neuropathological basis for depression in Parkinson's disease","volume":"15","author":"Frisina","year":"2009","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0060","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1212\/WNL.0b013e31820a0caf","article-title":"A cross-sectional study contrasting olfactory function in autonomic disorders","volume":"76","author":"Garland","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.neuro.2016.11.006_bib0065","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.pbb.2011.04.021","article-title":"Effects of anxiolytics in zebrafish: similarities and differences between benzodiazepines, buspirone and ethanol","volume":"99","author":"Gebauer","year":"2011","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.neuro.2016.11.006_bib0070","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1111\/j.1471-4159.2009.06403.x","article-title":"Pathogenesis of familial Parkinson's disease: new insights based on monogenic forms of Parkinson's disease","volume":"111","author":"Hatano","year":"2009","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuro.2016.11.006_bib0075","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.parkreldis.2013.07.008","article-title":"Predictive value of the smell identification test for nigrostriatal dopaminergic depletion in Korean tremor patients","volume":"19","author":"Hong","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0080","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.tips.2013.12.002","article-title":"Zebrafish as an emerging model for studying complex brain disorders","volume":"35","author":"Kalueff","year":"2014","journal-title":"Trends Pharmacol. Sci."},{"key":"10.1016\/j.neuro.2016.11.006_bib0085","doi-asserted-by":"crossref","first-page":"9884","DOI":"10.1073\/pnas.0900470106","article-title":"Olfactory neural circuitry for attraction to amino acids revealed by transposon-mediated gene trap approach in zebrafish","volume":"106","author":"Koide","year":"2009","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuro.2016.11.006_bib0090","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.1002\/mds.22233","article-title":"Anxiety rating scales in Parkinson's disease: critique and recommendations","volume":"23","author":"Leentjens","year":"2008","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0095","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1002\/mds.23368","article-title":"Nonmotor symptoms are independently associated with impaired health-related quality of life in Chinese patients with Parkinson's disease","volume":"25","author":"Li","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0100","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbr.2015.07.058","article-title":"Environment-contact administration of rotenone: a new rodent model of Parkinson's disease","volume":"294","author":"Liu","year":"2015","journal-title":"Behav. Brain Res."},{"issue":"Suppl. 1","key":"10.1016\/j.neuro.2016.11.006_bib0105","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1016\/j.parkreldis.2015.09.004","article-title":"Non-motor symptoms in Parkinson's disease","volume":"22","author":"Pfeiffer","year":"2016","journal-title":"Parkinsonism Relat. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0110","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1002\/mds.26424","article-title":"MDS clinical diagnostic criteria for Parkinson's disease","volume":"30","author":"Postuma","year":"2015","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0115","doi-asserted-by":"crossref","first-page":"2964","DOI":"10.1093\/brain\/awv215","article-title":"Clinical correlates of raphe serotonergic dysfunction in early Parkinson's disease","volume":"138","author":"Qamhawi","year":"2015","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2016.11.006_bib0120","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/S1474-4422(11)70073-4","article-title":"A double-blind, delayed-start trial of rasagiline in Parkinson's disease (the ADAGIO study): prespecified and post-hoc analyses of the need for additional therapies, changes in UPDRS scores, and non-motor outcomes","volume":"10","author":"Rascol","year":"2011","journal-title":"Lancet Neurol."},{"key":"10.1016\/j.neuro.2016.11.006_bib0125","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1046\/j.1468-1331.2003.00612.x","article-title":"Pramipexole and pergolide in the treatment of depression in Parkinson's disease: a national multicentre prospective randomized study","volume":"10","author":"Rektorova","year":"2003","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.neuro.2016.11.006_bib0130","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1002\/mds.23179","article-title":"Midbrain SERT in degenerative parkinsonisms: a 123I-FP-CIT SPECT study","volume":"25","author":"Roselli","year":"2010","journal-title":"Mov. Disord."},{"key":"10.1016\/j.neuro.2016.11.006_bib0135","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.pnpbp.2010.06.004","article-title":"Depressive-like behaviors alterations induced by intranigral MPTP, 6-OHDA, LPS and rotenone models of Parkinson's disease are predominantly associated with serotonin and dopamine","volume":"34","author":"Santiago","year":"2010","journal-title":"Prog. Neuropsychopharmacol. Biol. Psychiatry"},{"key":"10.1016\/j.neuro.2016.11.006_bib0140","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1002\/pmic.201500291","article-title":"1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine induced Parkinson's disease in zebrafish","volume":"16","author":"Sarath Babu","year":"2016","journal-title":"Proteomics"},{"key":"10.1016\/j.neuro.2016.11.006_bib0145","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1093\/brain\/awn323","article-title":"Gene expression profiling of substantia nigra dopamine neurons: further insights into Parkinson's disease pathology","volume":"132","author":"Simunovic","year":"2009","journal-title":"Brain"},{"key":"10.1016\/j.neuro.2016.11.006_bib0150","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00415-010-5666-5","article-title":"Preserved serotonin transporter binding in de novo Parkinson's disease: negative correlation with the dopamine transporter","volume":"258","author":"Strecker","year":"2011","journal-title":"J. Neurol."},{"key":"10.1016\/j.neuro.2016.11.006_bib0155","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0169-328X(00)00089-9","article-title":"Up-regulation of tyrosine hydroxylase mRNA in a sub-population of A10 dopamine neurons in Parkinson's disease","volume":"79","author":"Tong","year":"2000","journal-title":"Brain Res. Mol. Brain Res."},{"key":"10.1016\/j.neuro.2016.11.006_bib0160","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1176\/jnp.17.3.310","article-title":"Prevalence and treatment of depression in Parkinson's disease","volume":"17","author":"Veazey","year":"2005","journal-title":"J. Neuropsychiatry Clin. Neurosci."},{"key":"10.1016\/j.neuro.2016.11.006_bib0165","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1523\/JNEUROSCI.3642-15.2016","article-title":"G2019S-LRRK2 expression augments alpha-synuclein sequestration into inclusions in neurons","volume":"36","author":"Volpicelli-Daley","year":"2016","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuro.2016.11.006_bib0170","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/j.bbrc.2016.01.079","article-title":"Vesicular monoamine transporter 2 (Vmat2) knockdown elicits anxiety-like behavior in zebrafish","volume":"470","author":"Wang","year":"2016","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.neuro.2016.11.006_bib0175","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1124\/jpet.107.127597","article-title":"Mitochondrial complex I inhibitor rotenone-elicited dopamine redistribution from vesicles to cytosol in human dopaminergic SH-SY5Y cells","volume":"323","author":"Watabe","year":"2007","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"10.1016\/j.neuro.2016.11.006_bib0180","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0140-6736(05)70801-1","article-title":"Parkinson's disease in China: prevalence in Beijing, Xian, and Shanghai","volume":"365","author":"Zhang","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.neuro.2016.11.006_bib0185","doi-asserted-by":"crossref","first-page":"e0119928","DOI":"10.1371\/journal.pone.0119928","article-title":"Olfactory dysfunction and neurotransmitter disturbance in olfactory bulb of transgenic mice expressing human A53T mutant alpha-synuclein","volume":"10","author":"Zhang","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.neuro.2016.11.006_bib0190","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.parkreldis.2006.12.014","article-title":"Non-motor dysfunction in Parkinson's disease","volume":"13","author":"Ziemssen","year":"2007","journal-title":"Parkinsonism Relat. Disord."}],"container-title":["NeuroToxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X16302443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161813X16302443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T16:21:46Z","timestamp":1536250906000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161813X16302443"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":38,"alternative-id":["S0161813X16302443"],"URL":"https:\/\/doi.org\/10.1016\/j.neuro.2016.11.006","relation":{},"ISSN":["0161-813X"],"issn-type":[{"value":"0161-813X","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parkinson\u2019s disease-like motor and non-motor symptoms in rotenone-treated zebrafish","name":"articletitle","label":"Article Title"},{"value":"NeuroToxicology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuro.2016.11.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}